The First Two Portfolios. $660M Combined.

FyrstGen (fyrstgen.com) is the operational engine behind Portfolio I. It is the world's first industrialized IP commercialization platform — the company that sourced the 100 innovations in the portfolio, built the companies around them, and will manage their commercialization and exit.

FyrstGen operates through its proprietary CBaaS® (Company Building as a Service) model — a tech-enabled production system that takes validated intellectual property from universities and research institutions and turns it into exit-ready companies. The process is standardized, automated, and designed to run without dependence on any individual founder.

Fyrst Ltd. (Cayman Islands) is the holding entity and manager of the Wyoming LLC SPV. FyrstGen Holding Ltd. (UK) acts as service provider, applying the CBaaS® model on behalf of Fyrst Ltd. Investors participate through the Wyoming LLC, which holds 50% equity across all 100 portfolio companies.

The differences are structural, not incremental. Every existing model still depends on founders to execute. FyrstGen replaces founder execution entirely with a centralized, automated system.

FyrstGen is not a support model. It is a production system — IP goes in, exit-ready companies come out. The analogy is a car factory versus a bespoke craftsman. Both produce vehicles, but only one can operate at scale without the risk of any single individual's failure.

The short answer: scale is the feature, not the risk.

Each of the 100 companies follows an identical formation, governance, and commercialization playbook. There is no bespoke approach that breaks at volume — every company is built through the same automated system, with the same legal structure, the same brand development process, the same digital infrastructure, and the same exit logic.

Quality in this model is not managed manually — it is engineered into the system itself. FyrstGen's AI scores every IP submission before a company is created (as part of the selection process). Furthermore, companies that do not meet commercial milestones can be replaced within the portfolio. Progress to exit is tied to defined metrics, not to any individual's judgment on any given day.

Additionally, 100-company diversification means no single underperformer moves the needle on portfolio outcomes. This is not 100 startups each requiring individual attention. It is one repeatable system, running 100 times in parallel.

The 36-month timeline is achievable because FyrstGen compresses the traditional startup lifecycle by removing its primary bottlenecks — one by one, by design.

• No founder dependency → eliminates delays, pivots, leadership changes, and abandonment risk
• Pre-validated IP → skips early-stage ideation, discovery, and proof-of-concept phases
• Automated company creation → reduces setup time from months to days
• Centralized infrastructure → no rebuilding operations company by company
• Coordinated block exits → companies are positioned for group acquisition, not individual sales processes that take years

The traditional VC timeline of 7–10 years exists because it is built around individual founder journeys with unpredictable timelines. When you replace that with a centralized system and a coordinated exit strategy, the timeline compresses to what the commercial fundamentals actually require.

Capital is deployed into commercialization activities across the portfolio over a defined 36-month lifecycle. The return scenarios are modeled at portfolio level — not per individual company — across three exit rate assumptions:

These returns are driven by three variables: 100-company diversification, entry at a disciplined $3.2M pre-money valuation (below the US pre-seed average of $5M+), and coordinated block exits targeting $12M–$30M per company. Non-exited companies retain their entry-level valuation in all scenarios.

The 90% startup failure rate is real — and it is almost entirely caused by the factors that FyrstGen eliminates before a single dollar is deployed.

Startups fail primarily due to: founder-driven decisions under pressure (ego, fear, poor judgment), lack of commercial validation before significant investment, misaligned incentives across the cap table, execution inconsistency at scale, and insufficient market access. FyrstGen's model removes every one of these variables by design.

The companies in this portfolio are not fragmented startups trying to find their way. They are 100 instances of the same validated, automated system — starting with pre-validated IP, built through a standardized process, with centralized distribution infrastructure already in place.

The 50% average scenario is conservative relative to a portfolio where the primary causes of failure have been structurally eliminated. The conservative scenario — 30% exit rate — is the floor we model against.

Standardization is a core feature of the CBaaS® model — and the $3.2M entry valuation reflects deliberate market discipline, not arbitrary pricing.

Pre-seed valuations in the United States typically range from $3M to $10M, with averages around $5M+. Setting entry at $3.2M — the lower end of that range — serves two purposes: it provides strong upside for early investors, and it anchors valuation to commercial reality rather than narrative.

Exit valuation is not modeled as a multiple of revenue or EBITDA — it is anchored to commercialization activity. Specifically, it is tied to the volume of binding orders placed by distributors and commercial partners during the commercialization phase. This makes exit pricing significantly more defensible than narrative-driven startup pricing, because it reflects actual confirmed demand rather than projected growth.

No — and the distinction matters precisely because it affects how incentives are aligned.

In an average setup, a fee is paid regardless of outcome. It is extracted before investors see returns. It reduces the capital available for the portfolio to perform. Fyrst Ltd.'s 25% equity stake is the opposite: it is illiquid until exit, worth exactly nothing if the portfolio underperforms, and worth exactly what success produces — no more.

Fyrst Ltd.'s 25%, the IP owner's 25%, and the investor's 50% share one P&L. There is no management fee. No annual carry. No 2-and-20 structure extracted ahead of you. If exits underperform, Fyrst's 25% underperforms proportionally alongside your 50%. The incentive is perfectly aligned.

Additionally, the 25% reflects full-stack execution responsibility — building, branding, operating, distributing, and exiting 100 companies. This is not advisory access or a logo on a presentation. It is end-to-end delivery with no payout unless it works.

Investors subscribe through the Akemona platform, which handles accredited investor verification, digital securities issuance, and regulatory compliance. Full offering documents — including the Private Placement Memorandum — are available through the Akemona portal.

The portfolio is specifically structured to ensure that no single company failure affects the overall outcome. Several protection mechanisms operate simultaneously:

• 100-company diversification — no single company represents more than 1% of the portfolio. A company failing has minimal mathematical impact on aggregate returns.
• Company replacement — the Portfolio Manager (Fyrst Ltd.) retains the right to replace underperforming companies with better-positioned alternatives, in the interest of investors.
• Non-exited company floor — companies that do not reach an exit event retain their entry-level valuation ($3.2M pre-money). They are not written to zero.
• Cash reserve — a portion of the raised capital is retained as a reserve to protect investor capital and fund portfolio operations through the exit window.

The conservative scenario (30% exit rate, $12M average exit) models the portfolio with 70% of companies not reaching an exit event. Even at that floor, the projected return is 1.82× MOIC (83% ROI).

FyrstGen's model was specifically designed to democratize access to value creation — extending it to innovators who have the ideas but not the resources, networks, or appetite for the risks of entrepreneurship.

Under the standard equity split, every IP owner receives a 25% non-dilutive equity stake in the company built around their innovation. They receive this without putting in capital, without taking on operational responsibility, and without bearing the risks of starting a company. In fact, they remain completely passive in the company building process; furthermore, if the company exits, they participate fully in the upside.

25% to an innovator under this model is inherently better than industry standard. University technology transfer agreements typically give innovators far less — often 5–15% of a company that may never be formed, with years of uncertainty. FyrstGen creates the company, funds it, operates it, and takes it to exit. The innovator receives their equity stake from the moment the company is incorporated.

For the Portfolio I innovators specifically — each of the 100 IP owners receives their 25% equity stake in their respective company. A successful exit is a shared capital event for the investor and the original innovator alike.

The portfolio addresses 10 of the 17 UN Sustainable Development Goals across sectors including clean energy, sustainable agriculture, health technology, mobility, water and sanitation, waste management, safety, and climate solutions.

All impact figures are modeled on a portfolio simulation of 100 companies reaching commercial scale (approximately $20M exit value each — the midpoint of the average and best-case scenarios):

• 30,000+ New Jobs: Direct employment within successful portfolio companies, plus indirect employment across supply chains and related economic activity, based on employment multipliers at ~$20M commercial scale.
• 300,000+ tCO₂e reduction: Aggregated annual emission reduction estimates from climate-relevant technologies in the portfolio, modeled at commercial deployment scale.
• 40M+ Lives improved: Estimated market reach of deployed solutions across target regions, including indirect beneficiaries of infrastructure, environmental, and health innovations.

Portfolio I is not simply the first in a series — it is the only portfolio where accredited investors can participate at a $50,000 minimum and a $3.2M entry valuation. Both of those terms are permanent. They do not repeat.

The Women-for-Women Portfolio is the second portfolio in the FyrstGen pipeline, opening Q2 2026. It applies the identical CBaaS® model and structure as Portfolio I, with one key distinction: all 100 to 500 portfolio companies will be built around IP originated by women innovators and women-led research teams.

• Minimum investment: $500,000
• Entry valuation: $4.0M pre-money per company (standard rate)
• Number of companies: up to 500
• Offering target: $500M+
• Timeline: Q2 2026 launch, 36-month exit window

The Women-for-Women Portfolio targets family offices, ESG-mandated allocators, female-led funds, and foundations with gender equity mandates. Portfolio I investors receive priority allocation rights.

• Step 1 — Review the offering documents: The Private Placement Memorandum (PPM) and related documents are available through the Akemona platform. Review them carefully before making any investment decision.
• Step 2 — Complete accredited investor verification: US investors must be verified as accredited under Regulation D. International investors must qualify under Regulation S. Akemona handles this verification digitally.
• Step 3 — Subscribe through Akemona: Once verified, complete your subscription through Akemona's SEC-registered platform. Subscriptions are processed in order of receipt. The offering is capped at $160M.